Home » Topics » Regulatory

Regulatory
RSS

IND approved for new formulation of lidocaine

Feb. 17, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

FDA approves CellCept for new indication

Feb. 16, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Solvay and Elan to codevelop new formulation of fluvoxamine

Feb. 10, 1998

Lovenox approved for at-home use in U.S.

Feb. 9, 1998

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

P&U receives three-year marketing exclusivity for Rogaine Extra Strength

Feb. 6, 1998

Zestril introduced for new indication in U.K.

Feb. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.